STIMIT Activator 1 IDE Study

Last updated: November 13, 2025
Sponsor: Stimit AG
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Stimit Activator 1

Clinical Study ID

NCT05883163
D-26606
  • Ages > 21
  • All Genders

Study Summary

The study is a prospective, multi-center, randomized, controlled study using adaptive design to assess the evidence of safety and performance of the STIMIT Activator 1 System in the treatment of patients who have been mechanically ventilated for up to 7 days and are predicted to require additional minimum 48 hours of mechanical ventilation or longer.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Are 21 years or older, and,

  2. Have recently been placed on invasive MV (enroll and randomized as soon as possibleafter intubation), and have received no more than 7 days of MV

  3. Are predicted to remain on mechanical ventilation for an additional 48 hours orlonger post randomization

Exclusion

Exclusion Criteria:

  1. Patients that are actively treated with continuous infusion of neuromuscularblocking agents beyond the enrollment period.

  2. Medical condition known to affect the phrenic nerve or respiratory muscles (examplesof possible medical conditions that could affect the phrenic nerve provided in Annex 1 below).

  3. Any patients with ICP probe.

  4. Patients with metallic device implants or body penetrating metallic devices in theupper body area within 30cm (12inches) from the coils; known anatomy or devices inthe neck area (e.g., ECMO cannulas in the neck area, collars or cranial appliances)that would interfere with headset placement or stimulation.

  5. Any non-removable electrical / electronic device (device internal or external) thatmay be prone to interaction with, or interference from the STIMIT Activator, such aspacemakers, implantable defibrillators, implanted medication pumps, bio-stimulators,deep brain stimulators, implanted nerve stimulator, deep brain stimulators orcochlear device implants.

  6. BMI >40.

  7. Cardiogenic or septic shock with ongoing severe hemodynamic instability that cannotbe stabilized within the enrollment period.

  8. Physician thinks that the patient will not tolerate initial installation of theSTIMIT respiratory sensor.

  9. Anticipating withdrawal of life support and/or shift to palliation as the goal ofcare.

  10. Known to be pregnant.

  11. Participating in another clinical trial studying an experimental Intervention thatcould affect the study primary outcome.

  12. Patients whose ultrasonographic assessment of right-sided diaphragmatic thicknesswould be too difficult (e.g. local subcutaneous emphysema surrounding the zone ofapposition, large dressings in the zone of apposition that cannot be removed).

  13. Patients with neck condition that would not allow placing the coils on the neck (e.g. open wounds that cannot be covered, skin at risk for burns).

  14. Patients with significant spontaneous efforts (P0.1 < - 2) that would not be at riskfor diaphragmatic atrophy/ dysfunction.

Study Design

Total Participants: 40
Treatment Group(s): 1
Primary Treatment: Stimit Activator 1
Phase:
Study Start date:
January 24, 2024
Estimated Completion Date:
July 31, 2026

Study Description

The objective of this clinical investigation is to evaluate the safety and effectiness of the STIMIT Activator 1 System in patients who are on invasive mechanical ventilation (MV) and thus are at risk of diaphragmatic dysfunction/atrophy.

The study is expected to enroll 40 participants at up to 8 centers focusing on North American sites (main focus USA, > 50% of study enrollment from US site). An interim analysis will be conducted after 30 participants have been enrolled and compelted their study follow-up to reconfirm sample size (adaptive design). Participants will be followed for up to 10 days or until they are successfully extubated (weaned) from mechanical ventilation, expire prior to extubation, or withdraw consent.

Connect with a study center

  • St Michael's Hospital Unity Health Toronto

    Toronto 6167865,
    Canada

    Active - Recruiting

  • YALE New Haven Hospital

    New Haven, Connecticut 06510
    United States

    Site Not Available

  • Yale New Haven Hospital

    New Haven 4839366, Connecticut 4831725 06510
    United States

    Active - Recruiting

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts 02215
    United States

    Site Not Available

  • Beth Israel Deaconess Medical Center

    Boston 4930956, Massachusetts 6254926 02215
    United States

    Active - Recruiting

  • University of Virginia Medical Center

    Charlottesville, Virginia 22908
    United States

    Site Not Available

  • University of Virginia Medical Center

    Charlottesville 4752031, Virginia 6254928 22908
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.